Sign in
TerminatedNo phase

Virtual Reality for Enhancement of Vision

Key facts

Who runs it
Stanford University
Where
Palo Alto, United StatesSee the site
Trial code
Status
Terminated
People taking part
22 people enrolled
Started
17 Apr 2018
Ended
7 Sept 2025
Type of study
Interventional, 2 groups
Treatments tested
  • Virtual Reality Stimulation
Record updated
10 December 2025
Why it stopped
Due to Covid pandemic

Who can take part

Age
12 years and older
Sex
Women and men
Healthy volunteers
Can take part
Show the full registry criteria (14)Hide the full registry criteria

Who can take part

  • For subjects with glaucoma, other retinal diseases, or disorders of the visual system:
  • 1. Patient age > 12 years
  • 2. Compliance with investigator instructions, tests and visit during subject participation in the study
  • 3. Sufficient fixation ability
  • 4.Best corrected visual acuity of 20/200 or better in at least one eye, or capable to see the visual stimulus at least in one eye; For healthy volunteers:
  • 1. Patient age > 12 years
  • 2. Compliance with investigator instructions, tests and visit during subject participation in the study
  • 3.Best corrected visual acuity of 20/20 in both eyes
  • 4. Sufficient fixation ability

Who cannot take part

  • 2. Any metal artifacts in the head or truncus area (with the exception of dental implants)
  • 1. Electric or electronic implants (such as cardiac pacemaker)
  • 3. Epilepsy and photo-sensibility; acute auto-immune diseases
  • 4. Acute conjunctivitis
  • 5. Pathological nystagmus

Where in United States

  • Byers Eye Institute at Stanford UniversityPalo Alto, United States

About the trial

What the trial wants to find out

This project aims to evaluate the use of Virtual Reality (VR) based visual stimulation for the treatment of blindness arising from Glaucoma and other retinal diseases or disorders of the visual system, through regeneration of axons of retinal ganglion cells (RGCs) in humans.

Read full original descriptionShow less

In certain cases of blindness, such as in Glaucoma, or in certain injuries, the optic nerves behind the retina of our eyes get damaged, leading to partial blindness, mostly near the periphery of our eye. Recent research in Dr.Huberman's laboratory has identified visual stimulation as a non-invasive model for regeneration of such damaged axons in rodents, back to the vision centers of their brain.

The 2 groups in the trial

  • Virtual Reality Stimulation in Patients with Eye DisordersTreatment being tested

    Participants use the VR headset for up to 1 year, followed by 1 year follow-up period.

    Treatment: Virtual Reality Stimulation

  • Virtual Reality Stimulation in Participants with Normal VisionTreatment being tested

    Participants use the VR headset for up to 1 year, followed by 1 year follow-up period.

    Treatment: Virtual Reality Stimulation

Results explained

A paper that names this trial, explained in plain words.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Publications
Record updated
10 December 2025